PTX-COVID19-B
id:
ptx-covid19-b-306-17464469
title:
PTX-COVID19-B
text:
PTX-COVID19-B is a messenger RNA (mRNA)-based COVID-19 vaccine, a vaccine for the prevention of the COVID-19 disease caused by an infection of the SARS-CoV-2 coronavirus, created by Providence Therapeutics—a private Canadian drug company co-founded by Calgary, Alberta-based businessman Brad T. Sorenson and San Francisco–based Eric Marcusson in 2013. A team of eighteen working out of Sunnybrook Research Institute in Toronto, Ontario developed PTX-COVID19-B in less than four weeks, according to th
brand slug:
wiki
category slug:
encyclopedia
description:
Vaccine candidate against SARS-CoV-2 (COVID-19)
original url:
https://en.wikipedia.org/wiki/PTX-COVID19-B
date created:
date modified:
2023-10-14T21:27:51Z
main entity:
{"identifier":"Q106102944","url":"https://www.wikidata.org/entity/Q106102944"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/9/94/Coronavirus._SARS-CoV-2.png","width":2048,"height":2048}
fields total:
13
integrity:
15